State Street Corp Hille Vax, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Hille Vax, Inc. stock. As of the latest transaction made, State Street Corp holds 585,795 shares of HLVX stock, worth $1.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

585,795

Previous 595,445 1.62%

Holding current value

$1.12 Million

Previous $8.61 Million 88.04%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.58 - $14.42 $15,247 - $139,153	-9,650 Reduced 1.62%	585,795 $1.03 Million
Q2 2024 Aug 14, 2024	BUY	$11.86 - $15.93 $1.27 Million - $1.7 Million	106,711 Added 21.83%	595,445 $8.61 Million
Q1 2024 May 15, 2024	BUY	$14.15 - $19.75 $1.01 Million - $1.41 Million	71,488 Added 17.13%	488,734 $8.13 Million
Q4 2023 Feb 14, 2024	BUY	$10.35 - $17.11 $633,585 - $1.05 Million	61,216 Added 17.19%	417,246 $6.7 Million
Q3 2023 Nov 14, 2023	BUY	$11.59 - $16.7 $26,448 - $38,109	2,282 Added 0.65%	356,030 $4.79 Million
Q2 2023 Aug 14, 2023	BUY	$12.93 - $18.76 $1.04 Million - $1.51 Million	80,711 Added 29.56%	353,748 $6.08 Million
Q1 2023 May 15, 2023	BUY	$14.73 - $18.18 $186,570 - $230,267	12,666 Added 4.86%	273,037 $4.51 Million
Q4 2022 Feb 14, 2023	BUY	$13.52 - $21.46 $557,483 - $884,881	41,234 Added 18.82%	260,371 $4.36 Million
Q3 2022 Nov 15, 2022	BUY	$10.5 - $22.01 $577,132 - $1.21 Million	54,965 Added 33.48%	219,137 $3.75 Million
Q2 2022 Aug 15, 2022	BUY	$8.7 - $20.18 $1.43 Million - $3.31 Million	164,172 New	164,172 $1.79 Million

Others Institutions Holding HLVX

# of Institutions

Shares Held

36.1M

Call Options Held

Put Options Held

View Full List

About HilleVax, Inc.

Ticker HLVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,427,200
Market Cap $63.8M
Description
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.

More about HLVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Hille Vax, Inc. Transaction History